Etoposide(VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia

N. Esumi, S. Todo, S. Arakawa, S. Imashuku

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Etoposide(VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia'. Together they form a unique fingerprint.